10-K · March 31, 2026
GoHealth presents a consumer-focused, AI-enabled Medicare marketplace anchored on its Encompass operating model and proprietary LeadScore/PlanFit technologies, targeting ~68.0 million Medicare-eligible Americans.…
Earnings analysis · 10-Q
GOCO earnings analysis
Filed May 18, 2026 · Our reading of the company's report
The latest report
GoHealth, Inc. reported a significant decline in Q1 2026 financial performance, with revenues of $11.914 million, down 94.6% year-over-year, and an operating loss of $34.794 million. The company continues to face…
Read full summary
GoHealth, Inc. reported a significant decline in Q1 2026 financial performance, with revenues of $11.914 million, down 94.6% year-over-year, and an operating loss of $34.794 million. The company continues to face challenges in the Medicare market following a strategic pullback in Medicare Advantage activities, resulting in a substantial negative sentiment around its cash flow and profitability.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-37.17
What stood out
-
Sharp Revenue Decline
Revenue fell to $11.914 million from $220.972 million a year ago, representing a 94.6% decline.
-
Increasing Operating Losses
Operating loss escalated to $34.794 million for the quarter compared to an income of $6.669 million in the same quarter last year.
-
Costs Pressure
Total operating expenses decreased to $46.708 million from $214.303 million, but still contributed to heavy losses.
-
Decrease in Consumer Engagement
Submissions dropped dramatically to 18,615 from 303,026 year-over-year, a 93.9% decline.
-
Positive Operating Cash Flow
Operating cash flow turned positive, at $6.986 million, compared to a negative $12.405 million in Q1 2025.
-
Elevated Interest Expenses
Interest expense grew significantly to $30.786 million from $15.954 million, largely due to increased borrowings.
What to watch
-
Severe Liquidity Risk
Management expressed substantial doubt about the company's ability to continue as a going concern due to liquidity covenant risks.
-
Revenue Concentration Risk
The company's focus shift toward GoHealth Protect and away from traditional Medicare Advantage has raised concerns about revenue stability.
-
High Debt Levels
Total debt remained high at $701.8 million, with an effective interest rate of 14.65%, creating sustainability risks.
Management's outlook
Management anticipates ongoing challenges amid strategic adjustments and liquidity concerns.
Earlier filings 4
10-Q · November 14, 2025
GoHealth reported a sharp revenue collapse to $34,186,000 in Q3 2025 and a heavy GAAP loss driven by a large impairment; net loss for the quarter was $(313,918,000) and net loss attributable to GoHealth, Inc. was…
10-Q · November 7, 2024
GoHealth reported net revenues of $118,292 for the quarter ended September 30, 2024, down from $132,037 in the prior-year quarter (a $13,745 decline). Operating loss widened to $(42,672) (operating margin -36.1%) while…
10-Q · May 9, 2023
GoHealth reported Q1 2023 revenue of $183.158M, down from $270.593M in Q1 2022 (‑$87.435M, ‑32.3%), while operating loss narrowed to $(5.749)M from $(25.308)M a year ago and net loss per Class A share improved to…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.